These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27187546)

  • 1. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis.
    Ünal S; Açar B; Yayla Ç; Balci MM; Ertem A; Kara M; Maden O; Dereağzi ŞF
    Coron Artery Dis; 2016 Sep; 27(6):478-82. PubMed ID: 27187546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
    Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
    Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Predictive Value of CHA
    Yilmaz S; Akboga MK; Aras D; Topaloglu S
    Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.
    Açikgöz SK; Açikgöz E; Çiçek G
    Angiology; 2020 May; 71(5):411-416. PubMed ID: 32030991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the CHA2DS2-VASC Score to Predict Adverse Outcomes in Patients Having Percutaneous Coronary Intervention.
    Orvin K; Bental T; Assali A; Lev EI; Vaknin-Assa H; Kornowski R
    Am J Cardiol; 2016 May; 117(9):1433-8. PubMed ID: 27001448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHA
    Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
    J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.
    Yadav M; Généreux P; Palmerini T; Caixeta A; Madhavan MV; Xu K; Brener SJ; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):1-10. PubMed ID: 24408084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of CHADS
    Li X; Zeng Z; Yang X; Wang H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):439. PubMed ID: 34525958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Duran M
    Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the CHA
    Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
    Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.